332 related articles for article (PubMed ID: 33170805)
1. Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis.
Pompura SL; Wagner A; Kitz A; LaPerche J; Yosef N; Dominguez-Villar M; Hafler DA
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33170805
[TBL] [Abstract][Full Text] [Related]
2. Emerging Functions of Regulatory T Cells in Tissue Homeostasis.
Sharma A; Rudra D
Front Immunol; 2018; 9():883. PubMed ID: 29887862
[TBL] [Abstract][Full Text] [Related]
3. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
4. Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
Mohiuddin IH; Pillai V; Baughman EJ; Greenberg BM; Frohman EM; Crawford MP; Sinha S; Karandikar NJ
Clin Immunol; 2016 May; 166-167():12-8. PubMed ID: 27154631
[TBL] [Abstract][Full Text] [Related]
5. Fine-tuning of regulatory T cell function: the role of calcium signals and naive regulatory T cells for regulatory T cell deficiency in multiple sclerosis.
Schwarz A; Schumacher M; Pfaff D; Schumacher K; Jarius S; Balint B; Wiendl H; Haas J; Wildemann B
J Immunol; 2013 May; 190(10):4965-70. PubMed ID: 23576680
[TBL] [Abstract][Full Text] [Related]
6. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells: balancing protection versus pathology.
Rakebrandt N; Littringer K; Joller N
Swiss Med Wkly; 2016; 146():w14343. PubMed ID: 27497235
[TBL] [Abstract][Full Text] [Related]
8. Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression.
Venken K; Hellings N; Broekmans T; Hensen K; Rummens JL; Stinissen P
J Immunol; 2008 May; 180(9):6411-20. PubMed ID: 18424765
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
[TBL] [Abstract][Full Text] [Related]
10. The role of FOXP3 in regulating immune responses.
Vent-Schmidt J; Han JM; MacDonald KG; Levings MK
Int Rev Immunol; 2014 Mar; 33(2):110-28. PubMed ID: 23947341
[TBL] [Abstract][Full Text] [Related]
11. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T Cells in Multiple Sclerosis.
Goverman JM
N Engl J Med; 2021 Feb; 384(6):578-580. PubMed ID: 33567197
[No Abstract] [Full Text] [Related]
13. T regulatory cells are markers of disease activity in multiple sclerosis patients.
Dalla Libera D; Di Mitri D; Bergami A; Centonze D; Gasperini C; Grasso MG; Galgani S; Martinelli V; Comi G; Avolio C; Martino G; Borsellino G; Sallusto F; Battistini L; Furlan R
PLoS One; 2011; 6(6):e21386. PubMed ID: 21731726
[TBL] [Abstract][Full Text] [Related]
14. Effects of natalizumab treatment on Foxp3+ T regulatory cells.
Stenner MP; Waschbisch A; Buck D; Doerck S; Einsele H; Toyka KV; Wiendl H
PLoS One; 2008 Oct; 3(10):e3319. PubMed ID: 18836525
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cells induced the enrichment of CD4
Jia L; Lu J; Zhou Y; Tao Y; Xu H; Zheng W; Zhao J; Liang G; Xu L
Clin Immunol; 2018 Dec; 197():118-129. PubMed ID: 30248398
[TBL] [Abstract][Full Text] [Related]
16. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
17. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
Valencia X; Yarboro C; Illei G; Lipsky PE
J Immunol; 2007 Feb; 178(4):2579-88. PubMed ID: 17277168
[TBL] [Abstract][Full Text] [Related]
18. Zfp335 establishes eTreg lineage and neonatal immune tolerance by targeting Hadha-mediated fatty acid oxidation.
Wang X; Sun L; Yang B; Li W; Zhang C; Yang X; Sun Y; Shen X; Gao Y; Ju B; Gao Y; Liu D; Song J; Jia X; Su Y; Jiao A; Liu H; Zhang L; He L; Lei L; Chen W; Zhang B
J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37843279
[TBL] [Abstract][Full Text] [Related]
19. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
[TBL] [Abstract][Full Text] [Related]
20. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
